A targeting ligand enhances infectivity and cytotoxicity of an oncolytic adenovirus in human pancreatic cancer tissues

被引：0
|
作者：
Yamamoto, Yuki [1 ,3 ]
Hiraoka, Nobuyoshi [2 ]
Goto, Naoko [1 ]
Rin, Yosei [1 ,3 ]
Miura, Kazuki [1 ,3 ]
Narumi, Kenta [1 ]
Uchida, Hiroaki [3 ]
Tagawa, Masatoshi [4 ]
Aoki, Kazunori [1 ]
机构：
[1] Division of Gene and Immune Medicine, National Cancer Center Research Institute, 5-1-1 Tsukiji, Chuo-ku, Tokyo,104-0045, Japan
[2] Division of Molecular Pathology, National Cancer Center Research Institute, 5-1-1 Tsukiji, Chuo-ku, Tokyo,104-0045, Japan
[3] Laboratory of Oncology, Tokyo University of Pharmacy and Life Sciences, 432-1 Horinouchi, Hachioji, Tokyo,192-0355, Japan
[4] Division of Pathology and Cell Therapy, Chiba Cancer Center Research Institute, 666-2 Nitona-chou, Chuo-ku, Chiba,260-0801, Japan
来源：
Journal of Controlled Release | 2014年 / 192卷
关键词：
Compendex;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Cancer cells
引用
下载
收藏
页码：284 / 293
相关论文
共 50 条
  • [31] Novel oncolytic adenovirus fully composed of adenovirus serotype 35 for treatment of pancreatic cancer
    Ono, Ryosuke
    Sakurai, Fuminori
    Mizuguchi, Hiroyuki
    CANCER SCIENCE, 2022, 113 : 1359 - 1359
  • [32] The oncolytic adenovirus AdΔΔ enhances selective cancer cell killing in combination with DNA-damaging drugs in pancreatic cancer models
    G Cherubini
    C Kallin
    A Mozetic
    K Hammaren-Busch
    H Müller
    N R Lemoine
    G Halldén
    Gene Therapy, 2011, 18 : 1157 - 1165
  • [33] The oncolytic adenovirus AdΔΔ enhances selective cancer cell killing in combination with DNA-damaging drugs in pancreatic cancer models
    Cherubini, G.
    Kallin, C.
    Mozetic, A.
    Hammaren-Busch, K.
    Mueller, H.
    Lemoine, N. R.
    Hallden, G.
    GENE THERAPY, 2011, 18 (12) : 1157 - 1165
  • [34] Systemic Administration of Fiber Redesigned Infectivity-Selective Oncolytic Adenovirus for Cancer Treatment
    Miura, Yoshiaki
    Han, Joohee
    Davydova, Julia
    Yamamoto, Masato
    MOLECULAR THERAPY, 2013, 21 : S157 - S157
  • [35] hTERT-promoter-dependent oncolytic adenovirus enhances the transduction and therapeutic efficacy of replication-defective adenovirus vectors in pancreatic cancer cells
    Onimaru, Manabu
    Ohuchida, Kenoki
    Mizumoto, Kazuhiro
    Nagai, Eishi
    Cui, Lin
    Toma, Hiroki
    Takayama, Koichi
    Matsumoto, Kunio
    Hashizume, Makoto
    Tanaka, Masao
    CANCER SCIENCE, 2010, 101 (03): : 735 - 742
  • [36] Development of Systemically Applicable Cancer-Targeted Oncolytic Adenovirus in Pancreatic Cancer
    Sato-Dahlman, Mizuho
    Miura, Yoshiaki
    Hajeri, Praveensingh
    Jacobsen, Kari
    Yanagiba, Chikako
    Yamamoto, Masato
    MOLECULAR THERAPY, 2020, 28 (04) : 164 - 164
  • [37] The development of oncolytic adenovirus expressing thymidine kinase targeting prostate cancer
    Lee, S. D.
    Kim, J. S.
    Lee, S. J.
    Chung, M. K.
    Lee, J. Z.
    EUROPEAN UROLOGY SUPPLEMENTS, 2007, 6 (02) : 81 - 81
  • [38] Cancer therapy with a replicating oncolytic adenovirus targeting the hypoxic microenvironment of tumors
    Post, DE
    Devi, NS
    Li, ZC
    Brat, DJ
    Kaur, B
    Nicholson, A
    Olson, JJ
    Zhang, ZB
    Van Meir, EG
    CLINICAL CANCER RESEARCH, 2004, 10 (24) : 8603 - 8612
  • [39] Use of Oncolytic Adenovirus Expressing IFN-α to Treat Pancreatic Cancer
    Salzwedel, A.
    LaRocca, C.
    Davydova, J.
    Yamamoto, M.
    PANCREAS, 2015, 44 (08) : 1411 - 1411
  • [40] CHEMOTHERAPY SENSITIZATION OF PANCREATIC CANCER WITH ONCOLYTIC ADENOVIRUS EXPRESSING INTERFERON-α
    Han, Joohee
    Armstrong, Leonard
    Brown, Eric
    Aoki, Kazunori
    Vickers, Selwyn
    Yamamoto, Masato
    Davydova, Julia
    JOURNAL OF GENE MEDICINE, 2014, 16 (7-8): : 246 - 247
12345